GB1292197A - Method for the disruption of viruses - Google Patents
Method for the disruption of virusesInfo
- Publication number
- GB1292197A GB1292197A GB2275770A GB2275770A GB1292197A GB 1292197 A GB1292197 A GB 1292197A GB 2275770 A GB2275770 A GB 2275770A GB 2275770 A GB2275770 A GB 2275770A GB 1292197 A GB1292197 A GB 1292197A
- Authority
- GB
- United Kingdom
- Prior art keywords
- viruses
- disrupted
- aqueous medium
- wetting agent
- polyoxyethylene sorbitan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20151—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82678369A | 1969-05-16 | 1969-05-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1292197A true GB1292197A (en) | 1972-10-11 |
Family
ID=25247524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2275770A Expired GB1292197A (en) | 1969-05-16 | 1970-05-12 | Method for the disruption of viruses |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE2023987C3 (enrdf_load_html_response) |
FR (1) | FR2051533B1 (enrdf_load_html_response) |
GB (1) | GB1292197A (enrdf_load_html_response) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE661402A (enrdf_load_html_response) * | 1964-03-20 |
-
1970
- 1970-05-12 GB GB2275770A patent/GB1292197A/en not_active Expired
- 1970-05-15 DE DE2023987A patent/DE2023987C3/de not_active Expired
- 1970-05-15 FR FR7017848A patent/FR2051533B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE2023987C3 (de) | 1979-05-03 |
DE2023987B2 (de) | 1978-09-07 |
FR2051533B1 (enrdf_load_html_response) | 1974-04-12 |
FR2051533A1 (enrdf_load_html_response) | 1971-04-09 |
DE2023987A1 (de) | 1970-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Webster et al. | Cross‐protection and cross‐reactive cytotoxic T cells induced by influenza virus vaccines in mice | |
KR910009346B1 (ko) | 안정화된 생 비루스 백신 및 그의 제조방법 | |
GB1450557A (en) | Adjuvant compositions and medicinal mixtures comprising them | |
BR9106374A (pt) | Vacina oral e processo de extrair uma imunoresponsta em um mamifero | |
PT86376A (en) | Process for the preparation of an adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide | |
Lahelle et al. | Hemagglutination with the GDVII strain of mouse encephalomyelitis virus | |
JPS5538314A (en) | Fat emulsion and its preparation | |
Nagai et al. | The pathogenicity of Newcastle disease virus isolated from migrating and domestic ducks and the susceptibility of the viral glycoproteins to proteolytic cleavage | |
Pulkkinen et al. | Plaque size heterogeneity: a genetic trait of lymphocytic choriomeningitis virus | |
GB1292197A (en) | Method for the disruption of viruses | |
Bro-Jørgensen | The interplay between lymphocytic choriomeningitis virus, immune function, and hemopoiesis in mice | |
GB1256456A (en) | Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations | |
JPS6314729A (ja) | 生ワクチン用改良安定剤、その製造法およびそれを含有するワクチン | |
Kolakofsky | Studies on the generation and amplification of Sendai virus defective-interfering genomes | |
IE40794L (en) | Influenza vaccine. | |
GR3026619T3 (en) | Inactivated respiratory syncytial viral vaccines | |
GB1481650A (en) | Chemical processes and products | |
JPS5665841A (en) | Purification of lactic acid | |
US3686394A (en) | Attenuated live rubella virus vaccine and method of production | |
GB1229306A (enrdf_load_html_response) | ||
GB1062703A (en) | Vaccine compositions | |
JPS6419023A (en) | Heat treatment of fibrinogen and fibrinogen preparation | |
Stalheim | Viable, avirulent Leptospira interrogans serotype pomona vaccine: Preservation in liquid nitrogen | |
JPS561895A (en) | Enzymic determination of monofunctional fatty acid | |
Glück et al. | New aspects concerning the immunogenicity of rabies vaccines produced in animal brains (duck embryo) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |